COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,648 Articles (22,913 medRxiv, 8,735 bioRxiv)

Most recent first Previous |  Page 250: Articles 2491-2500  | Next

SARS-CoV-2 3CLPro Dihedral Angles Reveal Allosteric Signaling
Evans, D. J., Sheraz, S., Lau, A. Y.
10.1101/2024.05.22.595309 — Posted: 2024-05-22
Survey data yields improved estimates of test-confirmed COVID-19 cases when rapid at-home tests were massively distributed in the United States
Santillana, M., Uslu, A. A., Urmi, T., Quintana, A., Druckman, J. N., Ognyanova, K., Baum, M., Perlis, R. H., Lazer, D.
10.1101/2024.05.21.24307697 — Posted: 2024-05-22
West African pre-pandemic cross-reactive antibody and cellular responses against SARS-CoV-2
Herrera, B. B., Chaplin, B., MBoup, S., Abdullahi, A., He, M., Fisher, S. M., Akanmu, S., Chang, C. A., Hamel, D. J., Gupta, R. K., Kanki, P. J.
10.1101/2024.05.21.24307417 — Posted: 2024-05-22
A Cell-Based Papain-like Protease (PLpro) Activity Assay for Rapid Detection of Active SARS-CoV-2 Infections and Antivirals
Jimenez-Campos, A. G., Maestas, L. I., Velappan, N., Beck, B., Ye, C., Wernsing, K., Mata-Solis, Y., Bruno, W. J., Bussmann, S. C., Bradfute, S., Baca, J. T., Rininsland, F. H.
10.1101/2024.05.21.24307588 — Posted: 2024-05-21
Higher frequency of interstate over international transmission chains of SARS-CoV-2 virus at the Rio Grande do Sul - Brazil state borders
Dezordi, F. Z., Silva Junior, J. V. J., Ruoso, T. F., Batista, A. G., Fonseca, P. M., Salvato, R. S., Gregianini, T. S., Lopes, T. R. R., Flores, E. F., Weiblen, R., Brites, P. C., Silva, M. d. M., da Rocha, J. B. T., Barbosa, G. d. L., Machado, L. C., da Silva, A. F., Paiva, M. H. S., Bezerra, M. F., Campos, T. d. L., Gräf, T., Sganzerla, D. A., Loreto, E. L. d. S., Wallau, G. d. L.
10.1101/2024.05.21.24307668 — Posted: 2024-05-21
Wearable Data Reveals distinct Characteristics of Individuals with Persistent Symptoms after a SARS-CoV-2 Infection
Ledebur, K., Wiedermann, M., Puta, C., Thurner, S., Klimek, P., Brockmann, D.
10.1101/2024.05.21.24307673 — Posted: 2024-05-21
Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion
Li, P., Faraone, J. N., Hsu, C. C., Chamblee, M., Zheng, Y.-M., Carlin, C., Bednash, J. S., Horowitz, J. C., Mallampalli, R. K., Saif, L. J., Oltz, E. M., Jones, D., Li, J., Gumina, R. J., Xu, K., Liu, S.-L.
10.1101/2024.05.20.595020 — Posted: 2024-05-21
Plasmacytoid dendritic cells are dispensable or detrimental in murine systemic or respiratory viral infections
Ngo, C., Rahmani, K., Valente, M., Collinet, N., Bessou, G., Fabregue, M., Sharkaoui, S., Mazzoli, S., Pierini-Malosse, C., Sansoni, A., Fiore, F., Laprie, C., GAYA, M., Gregoire, C., Broggi, A., Milpied, P., Escaliere, B., Phong, T., Fallet, M., Chasson, L., Tran, H., Le Bert, M., Malissen, B., ZARUBICA, A., DALOD, M., Tomasello, E.
10.1101/2024.05.20.594961 — Posted: 2024-05-21
Impact of COVID-19 pandemic on rates of congenital heart disease procedures among children: Prospective cohort analyses of 26,270 procedures in 17,860 children using CVD-COVID-UK consortium record linkage data.
Karthikeyan Suseeladevi, A., Denholm, R., Babu-Narayan, S., Sinha, S., Stoica, S., Dong, T., Angelini, G., Sudlow, C., Walker, V., Brown, K., Caputo, M., Lawlor, D. A., CVD-COVD-UK/COVID-IMPACT Consortum
10.1101/2024.05.20.24307597 — Posted: 2024-05-20
COVID-19 transmission dynamics in South Korea prior to vaccine distribution
Suh, J., Galanti, M., Yamana, T. K., Perini, M., Kaondera-Shava, R. F., Shaman, J.
10.1101/2024.05.17.24307538 — Posted: 2024-05-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).